Sun Pharma gets boost with US FDA approval for Gleevec
Sun Pharmaceutical announced it received approval from the US FDA for generic copies of Gleevec, a drug that treats chronic myeloid leukemia.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Chronic Leukemia | Chronic Myeloid Leukaemia | Gleevec | Leukemia | Pharmaceuticals